Skip to content
Abivax
Primary Menu
About Us
Company
Management Team
Board of Directors
Scientific Advisory Board
Science
Overview
Publications
Pipeline
Overview
Patients
ABX464 for UC
ABX464 for Crohn’s
ABX464 for RA
ABX464 for HIV
ABX196 for HCC
New Targets
News & Events
Press Releases
Press Coverage
Upcoming Events
Investors
Overview
Share Price
Investor Documents
Annual General Meeting
UEG Week 2019
Contact Us
Search
Search for:
Search
EN
FR
DE
News & Events
Press Coverage
2020
2019
2018
2017
2016
BioCentury
March 7, 2016
ABX464: Additional Phase IIa data
Reuters
February 29, 2016
Abivax updates on ABX464 study to treat HIV
Scrip
February 10, 2016
Video Interview: Armed With Promising Clinical Data, Abivax Seeks Partners
LabioTech
January 18, 2016
A Phase II HIV Antiviral from France Has Promising Results
1
2
